The Asia-Pacific Infertility Testing Market is accounted to reach USD 4,132.55 million by 2024 from USD 2,335.74 in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024.
The major factors driving the growth of this market are technological advancements and innovative testing products. On the other hand, high cost of ovulation testing and accuracy issues with testing kits may hinder the growth of the market.
The key market players for Asia-Pacific Infertility Testing Market are listed below;
Toyota Boshoku Corporation
Toyoda Gosei Co., Ltd.,
Adient and Lear Corporation.
The market is further segmented into;
Type
Material
End User
Geography
The Asia-Pacific infertility testing market is segmented on the basis of type, test kits, prescription mode, distribution channel and end user.
Based on, the global infertility testing market is segmented into female infertility testing and male infertility testing. The infertility testing market is dominated by female infertility testing with 58.5% market share in 2017, growing at the highest CAGR of 8.0% in the forecast period.
Based on type, female infertility testing is further segmented into ovulation testing, hysterosalpingography, laparoscopy, transvaginal ultrasound, ovarian reserve testing, hormone tests and others. Male infertility testing is sub segmented into DNA fragmentation, oxidative stress analysis, sperm penetration assay, computer aided semen analysis, sperm agglutination, microscopic examination and others.
Based on test kits are further sub divided into human Follicular Stimulating Hormone (FSH) urine test kits, luteinizing hormone (LH) urine test kits, human chorionic gonadotropin (HCG) hormone blood test kits and others. In 2017, the Luteinizing Hormone (LH) Urine Test kits are expected to dominate the market with 43.6% market share
Based on prescription mode, the global infertility testing market is segmented into prescription-based and over the counter (OTC) based. In 2017, over the counter (OTC) are expected to dominate the market with 84.0% market share.
Based on distribution channel, the global infertility testing market is classified into hospitals pharmacies, online pharmacies and pharmacies & drug stores. In 2017, the pharmacies & drug stores are expected to dominate the market with 51.0% market share.
Based on end user, the global infertility testing market is classified into fertility centers, hospitals and clinics, research institutes and cryobanks. In 2017, the Fertility Centres are expected to dominate the market with 42.2% market share.
Based on geography, the Asia-Pacific Infertility Testing Materials market is segmented into geographical regions, such as,
China,
Japan,
India,
South Korea,
Australia,
Thailand,
Malaysia,
Singapore,
Indonesia,
Philippines
Rest of Asia-Pacific
Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific Infertility Testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.
